Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exosomes injection on poor responder ovary
IRCT20091012002576N37Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Apr 2024
- Modality
- Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, single-arm trial of endothelial progenitor cell-derived exosomes in poor ovarian response (POR), sponsored by Tehran University of Medical Sciences. Started Apr 2024; status: completed.
02
Drugs
endothelial progenitor cell-derived exosomes
03
Conditions
poor ovarian response (POR)
Beyond the preview
Go deeper on IRCT20091012002576N37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20091012002576N37.